| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Transport Proteins | 40 | 2005 | 1028 | 4.240 |
Why?
|
| Cocaine | 56 | 2020 | 946 | 3.700 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 56 | 2014 | 412 | 3.070 |
Why?
|
| Membrane Glycoproteins | 40 | 2005 | 3690 | 2.660 |
Why?
|
| Nerve Tissue Proteins | 40 | 2005 | 4392 | 2.600 |
Why?
|
| Dopamine | 30 | 2014 | 1582 | 2.120 |
Why?
|
| Dopamine Uptake Inhibitors | 16 | 2020 | 287 | 2.060 |
Why?
|
| Carrier Proteins | 38 | 2003 | 4913 | 1.920 |
Why?
|
| Corpus Striatum | 19 | 2020 | 1218 | 1.270 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 21 | 2012 | 326 | 1.230 |
Why?
|
| Hallucinogens | 2 | 2022 | 212 | 1.170 |
Why?
|
| Cannabidiol | 2 | 2021 | 123 | 1.150 |
Why?
|
| Opioid-Related Disorders | 6 | 2024 | 2178 | 1.130 |
Why?
|
| Receptors, Dopamine D1 | 13 | 2020 | 276 | 1.120 |
Why?
|
| Brain Chemistry | 16 | 2005 | 952 | 1.080 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 8 | 2008 | 66 | 1.070 |
Why?
|
| Receptors, Dopamine D2 | 12 | 2020 | 471 | 1.000 |
Why?
|
| Macaca fascicularis | 32 | 2008 | 907 | 0.960 |
Why?
|
| Receptors, Dopamine | 20 | 2020 | 291 | 0.920 |
Why?
|
| Marijuana Abuse | 2 | 2019 | 411 | 0.830 |
Why?
|
| Putamen | 18 | 2006 | 289 | 0.830 |
Why?
|
| Receptors, Drug | 11 | 2001 | 156 | 0.820 |
Why?
|
| Tropanes | 6 | 2003 | 47 | 0.820 |
Why?
|
| Macaca mulatta | 24 | 2020 | 2341 | 0.810 |
Why?
|
| Membrane Transport Modulators | 5 | 2005 | 24 | 0.780 |
Why?
|
| Saimiri | 21 | 2021 | 337 | 0.780 |
Why?
|
| Caudate Nucleus | 17 | 2020 | 387 | 0.770 |
Why?
|
| Cannabis | 2 | 2018 | 446 | 0.740 |
Why?
|
| Vesicular Monoamine Transport Proteins | 2 | 2015 | 34 | 0.730 |
Why?
|
| Methylphenidate | 7 | 2008 | 479 | 0.720 |
Why?
|
| Brain | 41 | 2024 | 27171 | 0.700 |
Why?
|
| Tomography, Emission-Computed | 16 | 2005 | 1006 | 0.660 |
Why?
|
| Substance-Related Disorders | 7 | 2018 | 4416 | 0.630 |
Why?
|
| Radioligand Assay | 14 | 2010 | 364 | 0.630 |
Why?
|
| Organotechnetium Compounds | 4 | 2003 | 134 | 0.620 |
Why?
|
| Neurobiology | 2 | 2013 | 135 | 0.610 |
Why?
|
| Behavior, Animal | 10 | 2021 | 1865 | 0.610 |
Why?
|
| Cocaine-Related Disorders | 4 | 2020 | 459 | 0.610 |
Why?
|
| Marijuana Smoking | 2 | 2018 | 261 | 0.580 |
Why?
|
| Citalopram | 9 | 2008 | 402 | 0.580 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 3 | 2008 | 69 | 0.570 |
Why?
|
| Drug and Narcotic Control | 3 | 2018 | 144 | 0.570 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 12 | 2013 | 1145 | 0.570 |
Why?
|
| Dopamine Agonists | 6 | 2006 | 346 | 0.570 |
Why?
|
| Designer Drugs | 1 | 2017 | 21 | 0.550 |
Why?
|
| Binding, Competitive | 18 | 2006 | 1140 | 0.540 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 4040 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 12 | 2012 | 3719 | 0.510 |
Why?
|
| Narcotics | 1 | 2018 | 332 | 0.510 |
Why?
|
| Dopamine Agents | 7 | 2001 | 186 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2007 | 1242 | 0.490 |
Why?
|
| Stereoisomerism | 15 | 2006 | 614 | 0.470 |
Why?
|
| Serotonin | 11 | 2005 | 1049 | 0.460 |
Why?
|
| Tritium | 15 | 2005 | 702 | 0.460 |
Why?
|
| Symporters | 3 | 2005 | 362 | 0.450 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 590 | 0.440 |
Why?
|
| Central Nervous System Stimulants | 8 | 2017 | 1167 | 0.420 |
Why?
|
| Cannabinoids | 4 | 2017 | 174 | 0.410 |
Why?
|
| Psychotropic Drugs | 2 | 2017 | 879 | 0.400 |
Why?
|
| Structure-Activity Relationship | 15 | 2012 | 3051 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2007 | 576 | 0.390 |
Why?
|
| Analgesics, Opioid | 5 | 2024 | 3835 | 0.380 |
Why?
|
| Haloperidol | 2 | 2013 | 391 | 0.380 |
Why?
|
| Iodine Radioisotopes | 8 | 2001 | 1029 | 0.370 |
Why?
|
| Octanes | 2 | 2003 | 3 | 0.370 |
Why?
|
| Politics | 1 | 2018 | 822 | 0.370 |
Why?
|
| Parkinsonian Disorders | 2 | 2006 | 286 | 0.350 |
Why?
|
| Pyrrolidines | 2 | 2017 | 337 | 0.340 |
Why?
|
| Animals | 102 | 2024 | 168764 | 0.330 |
Why?
|
| Benzhydryl Compounds | 3 | 2010 | 939 | 0.330 |
Why?
|
| Drug Discovery | 2 | 2018 | 1064 | 0.320 |
Why?
|
| Ligands | 13 | 2006 | 3273 | 0.320 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 5 | 2001 | 88 | 0.300 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 39 | 0.300 |
Why?
|
| Desipramine | 1 | 2008 | 183 | 0.290 |
Why?
|
| Discrimination Learning | 2 | 2008 | 276 | 0.280 |
Why?
|
| Piperidines | 4 | 2001 | 1664 | 0.280 |
Why?
|
| Autoradiography | 10 | 2006 | 723 | 0.280 |
Why?
|
| Norepinephrine | 4 | 2006 | 900 | 0.270 |
Why?
|
| Parkinson Disease | 7 | 1998 | 2895 | 0.260 |
Why?
|
| Pentanones | 1 | 2006 | 12 | 0.260 |
Why?
|
| Association Learning | 1 | 2008 | 219 | 0.260 |
Why?
|
| Receptor, EphA4 | 1 | 2005 | 17 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2021 | 10729 | 0.260 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2005 | 23 | 0.250 |
Why?
|
| Receptor, EphB2 | 1 | 2005 | 31 | 0.250 |
Why?
|
| Serotonin Agents | 1 | 2005 | 29 | 0.250 |
Why?
|
| Positron-Emission Tomography | 7 | 2014 | 6547 | 0.250 |
Why?
|
| Parents | 1 | 2019 | 3592 | 0.250 |
Why?
|
| Alkenes | 1 | 2004 | 54 | 0.240 |
Why?
|
| Neostriatum | 4 | 2001 | 231 | 0.230 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2006 | 187 | 0.230 |
Why?
|
| Adaptation, Physiological | 3 | 2006 | 1308 | 0.220 |
Why?
|
| 3' Untranslated Regions | 3 | 2012 | 515 | 0.220 |
Why?
|
| Catechols | 1 | 2003 | 63 | 0.220 |
Why?
|
| Piperazines | 5 | 2001 | 2549 | 0.210 |
Why?
|
| Cognition | 1 | 2021 | 7049 | 0.210 |
Why?
|
| Phenylacetates | 1 | 2003 | 112 | 0.210 |
Why?
|
| Pyrans | 1 | 2003 | 47 | 0.210 |
Why?
|
| Drug Tolerance | 2 | 2021 | 363 | 0.200 |
Why?
|
| Receptors, Opioid, mu | 1 | 2004 | 165 | 0.200 |
Why?
|
| Amphetamine | 3 | 2007 | 222 | 0.200 |
Why?
|
| Emotions | 1 | 2014 | 2763 | 0.200 |
Why?
|
| Antipsychotic Agents | 5 | 2013 | 3076 | 0.190 |
Why?
|
| Cell Line | 9 | 2008 | 15543 | 0.190 |
Why?
|
| Motor Activity | 7 | 2003 | 2704 | 0.190 |
Why?
|
| Psychoses, Substance-Induced | 2 | 2017 | 98 | 0.190 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2005 | 302 | 0.190 |
Why?
|
| Binding Sites | 15 | 2003 | 6001 | 0.190 |
Why?
|
| Parkinson Disease, Secondary | 3 | 1997 | 118 | 0.180 |
Why?
|
| Mazindol | 3 | 2001 | 13 | 0.170 |
Why?
|
| Nitrogen | 2 | 2001 | 346 | 0.160 |
Why?
|
| Gene Expression Regulation | 4 | 2006 | 11888 | 0.160 |
Why?
|
| Male | 67 | 2020 | 363698 | 0.160 |
Why?
|
| Nortropanes | 2 | 1997 | 13 | 0.160 |
Why?
|
| Phenanthridines | 4 | 2006 | 49 | 0.160 |
Why?
|
| Impulsive Behavior | 1 | 2002 | 344 | 0.160 |
Why?
|
| Inpatients | 1 | 2011 | 2564 | 0.160 |
Why?
|
| Humans | 62 | 2024 | 765968 | 0.160 |
Why?
|
| Tissue Distribution | 7 | 2000 | 2266 | 0.160 |
Why?
|
| Aggression | 1 | 2004 | 748 | 0.160 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 3 | 1994 | 36 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1657 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3685 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2004 | 16047 | 0.150 |
Why?
|
| Tryptophan | 9 | 1975 | 483 | 0.150 |
Why?
|
| Substance Abuse Detection | 3 | 2017 | 301 | 0.150 |
Why?
|
| Alcoholism | 1 | 2008 | 1975 | 0.140 |
Why?
|
| Propiophenones | 2 | 2017 | 28 | 0.140 |
Why?
|
| Heroin | 1 | 2018 | 120 | 0.140 |
Why?
|
| Health Policy | 1 | 2010 | 2698 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 360 | 0.140 |
Why?
|
| Nerve Endings | 2 | 1996 | 103 | 0.140 |
Why?
|
| Receptors, Serotonin | 3 | 1994 | 210 | 0.140 |
Why?
|
| Transfection | 5 | 2007 | 5743 | 0.140 |
Why?
|
| Cloning, Molecular | 4 | 2005 | 4165 | 0.140 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 770 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2017 | 6853 | 0.140 |
Why?
|
| Melatonin | 1 | 2002 | 674 | 0.130 |
Why?
|
| Aminopyridines | 1 | 2000 | 576 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15880 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1402 | 0.130 |
Why?
|
| Benztropine | 1 | 1996 | 17 | 0.130 |
Why?
|
| Carbon Radioisotopes | 6 | 2010 | 543 | 0.130 |
Why?
|
| Administration, Oral | 4 | 2017 | 4015 | 0.130 |
Why?
|
| Stereotyped Behavior | 2 | 2008 | 133 | 0.130 |
Why?
|
| Naphthalenes | 1 | 2017 | 197 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2006 | 17594 | 0.130 |
Why?
|
| Phenethylamines | 2 | 2006 | 95 | 0.120 |
Why?
|
| Alkaloids | 1 | 2017 | 190 | 0.120 |
Why?
|
| Female | 44 | 2020 | 396112 | 0.120 |
Why?
|
| Benzazepines | 4 | 2006 | 308 | 0.120 |
Why?
|
| Mass Screening | 1 | 2011 | 5446 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2017 | 166 | 0.120 |
Why?
|
| Molecular Structure | 4 | 2012 | 1885 | 0.120 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 774 | 0.120 |
Why?
|
| Marketing | 1 | 2017 | 225 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2006 | 13400 | 0.120 |
Why?
|
| Fentanyl | 1 | 2018 | 457 | 0.120 |
Why?
|
| Models, Animal | 1 | 2021 | 2120 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2013 | 6972 | 0.110 |
Why?
|
| Hallucinations | 1 | 2017 | 373 | 0.110 |
Why?
|
| Indoles | 2 | 2017 | 1839 | 0.110 |
Why?
|
| Substantia Nigra | 3 | 2007 | 346 | 0.110 |
Why?
|
| Behavior, Addictive | 2 | 2017 | 423 | 0.110 |
Why?
|
| Kinetics | 6 | 2005 | 6274 | 0.110 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 2699 | 0.110 |
Why?
|
| Gene Expression | 1 | 2006 | 7584 | 0.110 |
Why?
|
| Dibenzazepines | 2 | 1983 | 26 | 0.100 |
Why?
|
| Mianserin | 2 | 1983 | 51 | 0.100 |
Why?
|
| Fluoxetine | 1 | 1996 | 729 | 0.100 |
Why?
|
| Alleles | 4 | 2013 | 6897 | 0.100 |
Why?
|
| Quinolines | 3 | 2006 | 769 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2018 | 1187 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 1881 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2739 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2000 | 1191 | 0.100 |
Why?
|
| Ephrin-B3 | 1 | 2011 | 12 | 0.100 |
Why?
|
| Rats | 16 | 2020 | 23707 | 0.100 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 91 | 0.090 |
Why?
|
| GAP-43 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Depression | 2 | 2022 | 8237 | 0.090 |
Why?
|
| Cyclic AMP | 2 | 2006 | 1467 | 0.090 |
Why?
|
| Indans | 1 | 1992 | 92 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2006 | 3672 | 0.090 |
Why?
|
| Esters | 1 | 2012 | 214 | 0.090 |
Why?
|
| Raclopride | 1 | 2010 | 98 | 0.090 |
Why?
|
| Ascorbic Acid | 3 | 1983 | 657 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 2592 | 0.090 |
Why?
|
| Violence | 1 | 2017 | 935 | 0.090 |
Why?
|
| Protein Binding | 9 | 2010 | 9296 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2007 | 5020 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2000 | 2224 | 0.080 |
Why?
|
| District of Columbia | 1 | 2010 | 159 | 0.080 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 118 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2897 | 0.080 |
Why?
|
| Hippocampus | 2 | 2011 | 3775 | 0.080 |
Why?
|
| Government Agencies | 1 | 2010 | 161 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2643 | 0.080 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2000 | 168 | 0.080 |
Why?
|
| Species Specificity | 3 | 2020 | 2406 | 0.080 |
Why?
|
| United States | 4 | 2018 | 72903 | 0.070 |
Why?
|
| Reversal Learning | 1 | 2008 | 55 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2243 | 0.070 |
Why?
|
| Managed Care Programs | 1 | 2013 | 934 | 0.070 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 3 | 2020 | 50 | 0.070 |
Why?
|
| Edetic Acid | 3 | 1983 | 274 | 0.070 |
Why?
|
| Autoreceptors | 1 | 2007 | 5 | 0.070 |
Why?
|
| Crime | 1 | 2008 | 206 | 0.070 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2011 | 543 | 0.070 |
Why?
|
| Macaca | 1 | 1988 | 413 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2002 | 1749 | 0.070 |
Why?
|
| Primates | 2 | 2001 | 518 | 0.070 |
Why?
|
| Dogs | 9 | 1985 | 3822 | 0.070 |
Why?
|
| Injections, Intramuscular | 1 | 2008 | 552 | 0.070 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 394 | 0.070 |
Why?
|
| Ephrins | 1 | 2006 | 28 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2001 | 1947 | 0.060 |
Why?
|
| Models, Chemical | 2 | 1999 | 608 | 0.060 |
Why?
|
| Sleep | 1 | 2002 | 4813 | 0.060 |
Why?
|
| Adolescent | 8 | 2019 | 88835 | 0.060 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2006 | 106 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 2006 | 457 | 0.060 |
Why?
|
| Neuropilin-1 | 1 | 2006 | 90 | 0.060 |
Why?
|
| Prescription Drugs | 1 | 2013 | 634 | 0.060 |
Why?
|
| Semaphorins | 1 | 2006 | 96 | 0.060 |
Why?
|
| Molecular Conformation | 2 | 2006 | 541 | 0.060 |
Why?
|
| Acclimatization | 1 | 2005 | 113 | 0.060 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2005 | 9 | 0.060 |
Why?
|
| Molecular Probes | 2 | 2000 | 307 | 0.060 |
Why?
|
| Maleimides | 1 | 2005 | 112 | 0.060 |
Why?
|
| Anxiety | 1 | 2020 | 4671 | 0.060 |
Why?
|
| Community Health Centers | 1 | 2008 | 469 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2761 | 0.060 |
Why?
|
| Internet | 1 | 2017 | 3106 | 0.060 |
Why?
|
| Luciferases | 2 | 2007 | 713 | 0.060 |
Why?
|
| Spiperone | 5 | 1985 | 31 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2005 | 8278 | 0.060 |
Why?
|
| Health Personnel | 1 | 2018 | 3390 | 0.060 |
Why?
|
| Phenytoin | 2 | 1983 | 189 | 0.060 |
Why?
|
| Biogenic Amines | 1 | 2003 | 53 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 822 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1574 | 0.050 |
Why?
|
| Contrast Media | 1 | 1997 | 5329 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2011 | 12768 | 0.050 |
Why?
|
| Response Elements | 1 | 2005 | 307 | 0.050 |
Why?
|
| Public Health | 1 | 2017 | 2680 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2005 | 2163 | 0.050 |
Why?
|
| Sulfhydryl Reagents | 1 | 2002 | 29 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 1430 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2008 | 952 | 0.050 |
Why?
|
| Manganese | 2 | 1983 | 395 | 0.050 |
Why?
|
| Minisatellite Repeats | 2 | 2013 | 162 | 0.050 |
Why?
|
| Macaca nemestrina | 1 | 2002 | 19 | 0.050 |
Why?
|
| Glycosylation | 1 | 2005 | 1100 | 0.050 |
Why?
|
| Base Sequence | 2 | 2005 | 12403 | 0.050 |
Why?
|
| Neurons | 2 | 2020 | 9525 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4562 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1524 | 0.050 |
Why?
|
| Employment | 1 | 2008 | 1106 | 0.050 |
Why?
|
| Membranes | 4 | 1983 | 164 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2005 | 5379 | 0.050 |
Why?
|
| Reinforcement Schedule | 2 | 1992 | 123 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1218 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2020 | 23601 | 0.050 |
Why?
|
| Receptors, Cannabinoid | 1 | 2001 | 43 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2171 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2005 | 1228 | 0.050 |
Why?
|
| Young Adult | 4 | 2019 | 59889 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1718 | 0.050 |
Why?
|
| Prevalence | 1 | 2018 | 15842 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2005 | 1965 | 0.040 |
Why?
|
| Synapses | 2 | 2002 | 1754 | 0.040 |
Why?
|
| Dopamine Antagonists | 5 | 1992 | 278 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7425 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 2001 | 417 | 0.040 |
Why?
|
| Cerebellum | 2 | 2006 | 1518 | 0.040 |
Why?
|
| Urban Population | 1 | 2008 | 2040 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2005 | 1202 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 2001 | 362 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2005 | 513 | 0.040 |
Why?
|
| Carbon Isotopes | 5 | 2006 | 451 | 0.040 |
Why?
|
| Mutation | 1 | 2005 | 30198 | 0.040 |
Why?
|
| Amines | 1 | 2001 | 281 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 1995 | 629 | 0.040 |
Why?
|
| Adult | 13 | 2019 | 223044 | 0.040 |
Why?
|
| Oxazines | 2 | 2000 | 358 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1884 | 0.040 |
Why?
|
| Motor Skills | 2 | 2000 | 516 | 0.040 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2000 | 164 | 0.040 |
Why?
|
| Receptor, trkB | 1 | 2020 | 122 | 0.040 |
Why?
|
| Wakefulness | 1 | 2006 | 1282 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 8102 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2226 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2001 | 780 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2686 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 1975 | 393 | 0.040 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2001 | 490 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1998 | 91 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1679 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26318 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 1999 | 461 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2020 | 414 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2001 | 366 | 0.040 |
Why?
|
| Rural Population | 1 | 2008 | 2317 | 0.040 |
Why?
|
| HIV Infections | 1 | 2024 | 17533 | 0.040 |
Why?
|
| Drug Design | 1 | 2002 | 1042 | 0.040 |
Why?
|
| Kidney | 4 | 2002 | 7066 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 2817 | 0.040 |
Why?
|
| Reaction Time | 1 | 2003 | 2086 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6203 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 4247 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3750 | 0.030 |
Why?
|
| Tryptophan Oxygenase | 3 | 1974 | 19 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 605 | 0.030 |
Why?
|
| Pyrroles | 2 | 2000 | 1119 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2004 | 1827 | 0.030 |
Why?
|
| Aging | 2 | 1999 | 8731 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1995 | 142 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1995 | 289 | 0.030 |
Why?
|
| Hospitals | 1 | 2008 | 3888 | 0.030 |
Why?
|
| Polysomnography | 1 | 2002 | 1859 | 0.030 |
Why?
|
| beta Catenin | 1 | 2020 | 1043 | 0.030 |
Why?
|
| COS Cells | 1 | 1996 | 1136 | 0.030 |
Why?
|
| Fluorescent Dyes | 3 | 1992 | 1930 | 0.030 |
Why?
|
| Sex Factors | 1 | 2008 | 10603 | 0.030 |
Why?
|
| Solubility | 5 | 1983 | 1078 | 0.030 |
Why?
|
| Dietary Carbohydrates | 3 | 1974 | 894 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 74840 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3715 | 0.030 |
Why?
|
| Isoelectric Focusing | 2 | 1985 | 148 | 0.030 |
Why?
|
| Age Factors | 2 | 2008 | 18380 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3737 | 0.030 |
Why?
|
| Models, Neurological | 2 | 1998 | 1747 | 0.030 |
Why?
|
| Conditioning, Operant | 2 | 1992 | 306 | 0.030 |
Why?
|
| Genotype | 2 | 2013 | 13024 | 0.030 |
Why?
|
| Self Administration | 2 | 1991 | 385 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2007 | 18973 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 2081 | 0.030 |
Why?
|
| Biotin | 2 | 1992 | 257 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2535 | 0.030 |
Why?
|
| Bicuculline | 2 | 1983 | 94 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7599 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1991 | 94 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 1992 | 81 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1992 | 139 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 6069 | 0.020 |
Why?
|
| Diazepam | 2 | 1983 | 215 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2011 | 137 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2006 | 2218 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4137 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 2453 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 1377 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 4772 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1998 | 3946 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2001 | 2033 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3529 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 1526 | 0.020 |
Why?
|
| Cost Control | 1 | 2013 | 624 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 1997 | 1037 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14448 | 0.020 |
Why?
|
| Middle Aged | 8 | 2013 | 223009 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1990 | 234 | 0.020 |
Why?
|
| Carbon Dioxide | 3 | 1969 | 1137 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1983 | 5767 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2005 | 6610 | 0.020 |
Why?
|
| Comorbidity | 1 | 2024 | 10563 | 0.020 |
Why?
|
| Glucose | 4 | 1994 | 4335 | 0.020 |
Why?
|
| Risk Management | 1 | 2013 | 559 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 17075 | 0.020 |
Why?
|
| Yohimbine | 1 | 1969 | 62 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2010 | 234 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2077 | 0.020 |
Why?
|
| Time Factors | 8 | 2005 | 40065 | 0.020 |
Why?
|
| 5-Hydroxytryptophan | 1 | 1968 | 33 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1978 | 0.020 |
Why?
|
| Pyridines | 1 | 2000 | 2888 | 0.020 |
Why?
|
| Digitonin | 3 | 1982 | 25 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1992 | 705 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2006 | 4808 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1990 | 631 | 0.020 |
Why?
|
| Child | 3 | 2002 | 80564 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39193 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2006 | 211 | 0.020 |
Why?
|
| Hydrazines | 1 | 1968 | 223 | 0.020 |
Why?
|
| Mice | 3 | 2020 | 81819 | 0.020 |
Why?
|
| Serum Albumin | 3 | 1974 | 675 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2006 | 36532 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
| Osmosis | 1 | 2006 | 103 | 0.020 |
Why?
|
| Simian immunodeficiency virus | 1 | 2011 | 812 | 0.020 |
Why?
|
| Cattle | 2 | 1982 | 3801 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14652 | 0.020 |
Why?
|
| Butaclamol | 1 | 1985 | 5 | 0.020 |
Why?
|
| Fluphenazine | 1 | 1985 | 35 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 1985 | 111 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1992 | 1147 | 0.010 |
Why?
|
| Dialysis | 2 | 1974 | 72 | 0.010 |
Why?
|
| Aged | 5 | 2013 | 171117 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 1724 | 0.010 |
Why?
|
| Reference Values | 1 | 1991 | 4908 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 287 | 0.010 |
Why?
|
| Receptors, Histamine | 1 | 1983 | 23 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1994 | 4184 | 0.010 |
Why?
|
| Quinolinic Acid | 2 | 1994 | 67 | 0.010 |
Why?
|
| Buffers | 1 | 1983 | 141 | 0.010 |
Why?
|
| Lipid Peroxides | 1 | 1983 | 73 | 0.010 |
Why?
|
| Apomorphine | 2 | 1994 | 148 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 1445 | 0.010 |
Why?
|
| Tromethamine | 1 | 1982 | 30 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2476 | 0.010 |
Why?
|
| Microglia | 1 | 2011 | 1372 | 0.010 |
Why?
|
| Adrenalectomy | 3 | 1969 | 344 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 967 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65188 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 1787 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 3432 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2006 | 6601 | 0.010 |
Why?
|
| Polyethylene Glycols | 2 | 1982 | 1188 | 0.010 |
Why?
|
| Amino Acids | 1 | 1965 | 1709 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2194 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1969 | 186 | 0.010 |
Why?
|
| Dietary Fats | 3 | 1975 | 2002 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2477 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1981 | 608 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 11022 | 0.010 |
Why?
|
| Chemistry | 2 | 1991 | 325 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1991 | 483 | 0.010 |
Why?
|
| MPTP Poisoning | 1 | 1996 | 36 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5929 | 0.010 |
Why?
|
| Oleic Acids | 2 | 1974 | 70 | 0.010 |
Why?
|
| Macrophages | 1 | 2011 | 5772 | 0.010 |
Why?
|
| Adrenal Glands | 2 | 1969 | 558 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 8923 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1996 | 389 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1974 | 94 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4241 | 0.010 |
Why?
|
| Iron | 1 | 1983 | 1816 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1994 | 150 | 0.010 |
Why?
|
| Milk | 1 | 1975 | 436 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1994 | 365 | 0.010 |
Why?
|
| Ibotenic Acid | 1 | 1992 | 59 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1992 | 108 | 0.010 |
Why?
|
| Electroshock | 1 | 1991 | 120 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1996 | 1417 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1992 | 321 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1992 | 238 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1974 | 931 | 0.010 |
Why?
|
| Levodopa | 1 | 1991 | 222 | 0.010 |
Why?
|
| Nomifensine | 1 | 1989 | 14 | 0.010 |
Why?
|
| Papio | 1 | 1992 | 671 | 0.010 |
Why?
|
| Muscles | 1 | 1974 | 1578 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1994 | 461 | 0.010 |
Why?
|
| Biogenic Monoamines | 1 | 1989 | 50 | 0.010 |
Why?
|
| Tyrosine | 1 | 1974 | 1428 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 551 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1974 | 1214 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 59489 | 0.000 |
Why?
|
| Betaine | 1 | 1968 | 90 | 0.000 |
Why?
|
| Tryptamines | 1 | 1968 | 94 | 0.000 |
Why?
|
| Leukemia, Experimental | 1 | 1968 | 225 | 0.000 |
Why?
|
| Bupropion | 1 | 1989 | 303 | 0.000 |
Why?
|
| Heme | 1 | 1969 | 316 | 0.000 |
Why?
|
| Ligases | 1 | 1968 | 330 | 0.000 |
Why?
|
| Asparaginase | 1 | 1968 | 240 | 0.000 |
Why?
|
| Xanthurenates | 1 | 1965 | 6 | 0.000 |
Why?
|
| Kynurenic Acid | 1 | 1965 | 44 | 0.000 |
Why?
|
| Light | 1 | 1992 | 1365 | 0.000 |
Why?
|
| Colorimetry | 1 | 1965 | 148 | 0.000 |
Why?
|
| Urine | 1 | 1965 | 360 | 0.000 |
Why?
|
| Body Weight | 1 | 1974 | 4622 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1992 | 2394 | 0.000 |
Why?
|
| Spleen | 2 | 1968 | 2296 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1992 | 2024 | 0.000 |
Why?
|
| Blood Glucose | 2 | 1974 | 6424 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1999 | 22223 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1981 | 173 | 0.000 |
Why?
|
| Liver | 2 | 1974 | 7562 | 0.000 |
Why?
|
| Graft Survival | 1 | 1992 | 3890 | 0.000 |
Why?
|
| Diet | 2 | 1975 | 8086 | 0.000 |
Why?
|
| Insulin | 1 | 1974 | 6599 | 0.000 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 624 | 0.000 |
Why?
|
| Pancreas | 1 | 1965 | 1700 | 0.000 |
Why?
|
| Neurotransmitter Agents | 1 | 1981 | 663 | 0.000 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1983 | 1140 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1965 | 3046 | 0.000 |
Why?
|
| Myocardium | 1 | 1965 | 4760 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1992 | 18293 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1973 | 697 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1975 | 959 | 0.000 |
Why?
|
| Benz(a)Anthracenes | 1 | 1968 | 11 | 0.000 |
Why?
|
| Methylcholanthrene | 1 | 1968 | 30 | 0.000 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1968 | 36 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1992 | 20659 | 0.000 |
Why?
|
| Diethylstilbestrol | 1 | 1968 | 84 | 0.000 |
Why?
|
| Asparagine | 1 | 1968 | 120 | 0.000 |
Why?
|
| Lung | 1 | 1965 | 10033 | 0.000 |
Why?
|
| Fasting | 1 | 1973 | 1606 | 0.000 |
Why?
|
| Testis | 1 | 1968 | 780 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1968 | 2014 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1968 | 1261 | 0.000 |
Why?
|
| Estrogens | 1 | 1968 | 1529 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1968 | 3454 | 0.000 |
Why?
|